These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 23651092)

  • 1. Cholera: pathophysiology and emerging therapeutic targets.
    Muanprasat C; Chatsudthipong V
    Future Med Chem; 2013 May; 5(7):781-98. PubMed ID: 23651092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of Virulence of Toxigenic Vibrio cholerae by Anethole through the Cyclic AMP (cAMP)-cAMP Receptor Protein Signaling System.
    Zahid MS; Awasthi SP; Asakura M; Chatterjee S; Hinenoya A; Faruque SM; Yamasaki S
    PLoS One; 2015; 10(9):e0137529. PubMed ID: 26361388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of cholera toxin with Vibrio cholerae outer membrane vesicles which are internalized by human intestinal epithelial cells.
    Chatterjee D; Chaudhuri K
    FEBS Lett; 2011 May; 585(9):1357-62. PubMed ID: 21510946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AC6 is the major adenylate cyclase forming a diarrheagenic protein complex with cystic fibrosis transmembrane conductance regulator in cholera.
    Thomas A; Ramananda Y; Mun K; Naren AP; Arora K
    J Biol Chem; 2018 Aug; 293(33):12949-12959. PubMed ID: 29903911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbes and microbial Toxins: paradigms for microbial-mucosal toxins. V. Cholera: invasion of the intestinal epithelial barrier by a stably folded protein toxin.
    Lencer WI
    Am J Physiol Gastrointest Liver Physiol; 2001 May; 280(5):G781-6. PubMed ID: 11292584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of virulence in Vibrio cholerae.
    Klose KE
    Int J Med Microbiol; 2001 May; 291(2):81-8. PubMed ID: 11437342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization.
    Hung DT; Shakhnovich EA; Pierson E; Mekalanos JJ
    Science; 2005 Oct; 310(5748):670-4. PubMed ID: 16223984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outer Membrane Vesicles of Vibrio cholerae Protect and Deliver Active Cholera Toxin to Host Cells via Porin-Dependent Uptake.
    Zingl FG; Thapa HB; Scharf M; Kohl P; Müller AM; Schild S
    mBio; 2021 Jun; 12(3):e0053421. PubMed ID: 34076466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vibrio cholerae infection, novel drug targets and phage therapy.
    Fazil MH; Singh DV
    Future Microbiol; 2011 Oct; 6(10):1199-208. PubMed ID: 22004038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugated Linoleic Acid Reduces Cholera Toxin Production In Vitro and In Vivo by Inhibiting Vibrio cholerae ToxT Activity.
    Withey JH; Nag D; Plecha SC; Sinha R; Koley H
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7471-6. PubMed ID: 26392502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of both acfA and acfD transcription by Vibrio cholerae ToxT requires binding to two centrally located DNA sites in an inverted repeat conformation.
    Withey JH; DiRita VJ
    Mol Microbiol; 2005 May; 56(4):1062-77. PubMed ID: 15853890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Vibrio cholerae virulence genes in response to environmental signals.
    Peterson KM
    Curr Issues Intest Microbiol; 2002 Sep; 3(2):29-38. PubMed ID: 12400636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vibrio cholerae: cholera toxin.
    Vanden Broeck D; Horvath C; De Wolf MJ
    Int J Biochem Cell Biol; 2007; 39(10):1771-5. PubMed ID: 17716938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Potent Inhibitor of the Cystic Fibrosis Transmembrane Conductance Regulator Blocks Disease and Morbidity Due to Toxigenic
    Rivera-Chávez F; Meader BT; Akosman S; Koprivica V; Mekalanos JJ
    Toxins (Basel); 2022 Mar; 14(3):. PubMed ID: 35324722
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathophysiological mechanisms of diarrhea caused by the Vibrio cholerae O1 El Tor variant: an in vivo study in mice.
    Satitsri S; Pongkorpsakol P; Srimanote P; Chatsudthipong V; Muanprasat C
    Virulence; 2016 Oct; 7(7):789-805. PubMed ID: 27222028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial-associated cholera toxin and GM1 binding are required for transcytosis of classical biotype Vibrio cholerae through an in vitro M cell model system.
    Blanco LP; DiRita VJ
    Cell Microbiol; 2006 Jun; 8(6):982-98. PubMed ID: 16681839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of 6-gingerol in reduction of cholera toxin activity in vitro and in vivo.
    Saha P; Das B; Chaudhuri K
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4373-80. PubMed ID: 23817372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive review of therapeutic approaches available for the treatment of cholera.
    Sousa FBM; Nolêto IRSG; Chaves LS; Pacheco G; Oliveira AP; Fonseca MMV; Medeiros JVR
    J Pharm Pharmacol; 2020 Dec; 72(12):1715-1731. PubMed ID: 32737883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vibrio cholerae cytolysin is essential for high enterotoxicity and apoptosis induction produced by a cholera toxin gene-negative V. cholerae non-O1, non-O139 strain.
    Saka HA; Bidinost C; Sola C; Carranza P; Collino C; Ortiz S; Echenique JR; Bocco JL
    Microb Pathog; 2008 Feb; 44(2):118-28. PubMed ID: 17919878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc oxide nanoparticles provide anti-cholera activity by disrupting the interaction of cholera toxin with the human GM1 receptor.
    Sarwar S; Ali A; Pal M; Chakrabarti P
    J Biol Chem; 2017 Nov; 292(44):18303-18311. PubMed ID: 28882894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.